Receptos

Receptos

Receptos is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative immunomodulatory and metabolic therapeutics. Our drug discovery engine leverages proprietary GPCR protein-based screening with receptor structure determination to enable rational drug development for high-value GPCR targets, such as sphingosine1-phosphate 1 receptor (S1P1R) and glucagon-like peptide-1 receptor (GLP-1R).

<< Portfolio

receptos